The world urgently needs 20 billion doses of a vaccine that will protect global citizens against the coronavirus. States are throwing huge sums of public money at the race to beat Covid-19, but who will get there first? Will Big Pharma focus on private profit? Will vaccine nationalism prevail, or will the patent be shared to create a low-cost global supply?
EN
Investigate Europe has identified several of the European Union’s Covid vaccine negotiators, whose names were not publicly disclosed by the Commission. Some appear to have maintained strong ties with the pharma industry.
Help bringour cross-border journalism to life.Support Investigate EuropeDonate
